Zealand Pharma A/S (ZLDPF) Short Interest Ratio & Short Volume $113.28 -1.32 (-1.15%) (As of 01:59 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Zealand Pharma A/S Short Interest DataZealand Pharma A/S (ZLDPF) has a short interest of 813,400 shares. This marks a 0.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 135.6, indicating that it would take 135.6 days of the average trading volume of 1,940 shares to cover all short positions.Current Short Interest813,400 sharesPrevious Short Interest812,300 sharesChange Vs. Previous Month+0.14%Dollar Volume Sold Short$84.63 millionShort Interest Ratio135.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares51,510,000 sharesPercentage of Shares Shorted1.58%Today's Trading Volume140 sharesAverage Trading Volume1,940 sharesToday's Volume Vs. Average7% Short Selling Zealand Pharma A/S? Sign up to receive the latest short interest report for Zealand Pharma A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartZLDPF Short Interest Over TimeZLDPF Days to Cover Over TimeZLDPF Percentage of Float Shorted Over Time Ad Huge AlertsUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Click here to see how this opportunity could transform your portfolio. Zealand Pharma A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024813,400 shares $84.63 million +0.1%N/A135.6 $104.05 11/15/2024812,300 shares $82.85 million -0.1%N/A290.1 $102.00 10/31/2024812,800 shares $93.47 million +0.3%N/A239.1 $115.00 10/15/2024810,600 shares $92.69 million +2.2%N/A386 $114.35 9/30/2024793,400 shares $97.19 million +5.0%N/A466.7 $122.50 9/15/2024755,300 shares $103.29 million +1.9%N/A302.1 $136.76 Get the Latest News and Ratings for ZLDPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024741,400 shares $93.42 million -0.1%N/A741.4 $126.00 8/15/2024741,900 shares $101.63 million -0.6%N/A570.7 $136.99 7/31/2024746,000 shares $99.23 million +21.4%N/A310.8 $133.01 7/15/2024614,500 shares $83.28 million +0.5%N/A120.5 $135.52 6/30/2024611,300 shares $79.07 million +2.8%N/A59.3 $129.35 6/15/2024594,600 shares $54.98 million +8.0%N/A198.2 $92.46 5/31/2024550,400 shares $51.18 million +16.2%N/A220.2 $92.98 5/15/2024473,700 shares $45.15 million +3.6%N/A315.8 $95.30 4/30/2024457,200 shares $41.90 million +11.6%N/A268.9 $91.65 4/15/2024409,800 shares $34.50 million +21.1%N/A102.5 $84.19 3/31/2024338,500 shares $33.85 million +8.4%N/A109.2 $100.00 3/15/2024312,400 shares $31.86 million -1.9%N/A29.5 $101.98 2/29/2024318,500 shares $30.89 million -40.2%N/A23.1 $97.00 2/15/2024532,800 shares $37.59 million -12.2%N/A409.8 $70.54 1/15/2024635,900 shares $40.79 million -10.3%N/A227.1 $64.14 12/31/2023795,700 shares $44.28 million -3.0%N/A723.4 $55.65 12/15/2023795,700 shares $41.34 million -3.0%N/A723.4 $51.95 11/30/2023820,400 shares $40.56 million -6.4%N/A1367.3 $49.44 11/15/2023890,400 shares $37.09 million +4.4%N/A4452 $41.66 10/31/2023890,400 shares $38.14 million +4.4%N/A4452 $42.84 10/15/2023852,800 shares $37.68 million -0.7%N/A8528 $44.18 9/30/2023858,400 shares $37.30 million -17.6%N/A2146 $43.46 9/15/20231,041,100 shares $43.44 million -16.9%N/A1735.2 $41.72 8/31/20231,252,100 shares $46.70 million -23.8%N/A8635.1 $37.30 8/15/20231,643,700 shares $58.10 million +3.0%N/A5479 $35.35 7/31/20231,596,100 shares $53.34 million +8.2%N/A7980.5 $33.42 7/15/20231,475,800 shares $49.97 million +23.3%N/A2951.6 $33.86 6/30/20231,196,700 shares $41.35 million +31.6%N/A3989 $34.55 6/15/2023909,700 shares $36.93 million +0.0%N/A3032.3 $40.60 5/31/2023909,400 shares $34.78 million +35.5%N/A1818.8 $38.25 5/15/2023671,300 shares $25.40 million -20.7%N/A559.4 $37.84 4/30/2023847,000 shares $28.69 million -3.9%N/A8470 $33.88 4/15/2023880,900 shares $27.40 million +3.0%N/A8809 $31.11 3/31/2023855,000 shares $29.82 million -1.4%N/A8550 $34.88Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 3/15/2023866,900 shares $27.75 million +36.0%N/A8669 $32.01 2/28/2023637,500 shares $19.63 million -1.9%N/A3187.5 $30.79 2/15/2023650,100 shares $19.06 million +3.2%N/A928.7 $29.32 1/31/2023630,200 shares $18.91 million -0.4%N/A3151 $30.00 1/15/2023632,600 shares $18.98 million -4.5%N/A3163 $30.00 12/30/2022662,500 shares $18.67 million -0.9%N/A1656.3 $28.18 12/15/2022668,800 shares $18.81 million -0.8%N/A2229.3 $28.12 11/30/2022674,300 shares $18.95 million -3.8%N/A613 $28.10 11/15/2022701,000 shares $18.97 million +9.8%N/A637.3 $27.07 10/31/2022638,500 shares $16.44 million -11.0%N/A912.1 $25.75 10/15/2022717,600 shares $16.72 million -4.5%N/A3588 $23.30 9/30/2022751,500 shares $17.25 million +4.0%N/A1503 $22.95 9/15/2022722,900 shares $13.02 million +1.9%N/A7229 $18.01 8/31/2022709,300 shares $13.58 million -31.5%N/A886.6 $19.15 8/15/20221,035,900 shares $16.98 million +33.5%N/A3453 $16.39 7/31/2022775,900 shares $11.71 million +1.3%N/A0 $15.09 7/15/2022766,000 shares $11.56 million -3.3%N/A3830 $15.09 6/30/2022791,700 shares $9.37 million +0.7%N/A7917 $11.83 6/15/2022786,000 shares $9.39 million -1.3%N/A7860 $11.95 5/31/2022796,200 shares $10.91 million +222.5%N/A7962 $13.70 5/15/2022246,900 shares $2.75 million -12.1%N/A2469 $11.14 4/30/2022280,900 shares $4.35 million +1.9%N/A0 $15.50 4/15/2022275,800 shares $4.27 million +7.9%N/A2758 $15.50 3/31/2022255,700 shares $4.14 million -1.9%N/A319.6 $16.20 3/15/2022260,700 shares $3.74 million +2.5%N/A0 $14.35 2/28/2022254,300 shares $3.65 million +581.8%N/A2543 $14.35 2/15/202237,300 shares $641,560.00 -1.6%N/A373 $17.20 1/31/202237,900 shares $873,595.00 -13.5%N/A379 $23.05 1/15/202243,800 shares $1.01 million +11.7%N/A73 $23.05 12/31/202139,200 shares $863,968.00 -37.3%N/A392 $22.04 12/15/202162,500 shares $1.60 million -9.2%N/A0 $25.65 11/30/202168,800 shares $1.76 million -14.5%N/A0 $25.65 11/15/202180,500 shares $2.06 million +6.6%N/A201.3 $25.65 10/29/202175,500 shares $2.39 million +1.2%N/A755 $31.65 10/15/202174,600 shares $2.21 million +16.4%N/A0 $29.65 9/30/202164,100 shares $1.90 million +105.5%N/A641 $29.65 9/15/202131,200 shares $868,920.00 -40.3%N/A312 $27.85 8/31/202152,300 shares $1.46 million +211.3%N/A523 $27.85 8/13/202116,800 shares $485,856.00 -75.8%N/A0 $28.92 7/30/202169,300 shares $2.00 million +20.1%N/A0 $28.92 7/15/202157,700 shares $1.67 million -16.6%N/A0 $28.92 6/30/202169,200 shares $2.00 million +15.7%N/A692 $28.92 6/15/202159,800 shares $1.95 million +15.0%N/A598 $32.60 5/28/202152,000 shares $1.70 million +7.4%N/A0 $32.60 5/14/202148,400 shares $1.58 million -20.1%N/A484 $32.60 4/30/202160,600 shares $1.98 million -46.3%N/A606 $32.60 4/15/2021112,900 shares $3.68 million +19.7%N/A1129 $32.60 3/31/202194,300 shares $2.96 million +74.6%N/A943 $31.40 3/15/202154,000 shares $1.71 million +12.3%N/A540 $31.65 2/26/202148,100 shares $1.62 million +14.8%N/A481 $33.59Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 2/12/202141,900 shares $1.41 million +6.6%N/A419 $33.59 1/29/202139,300 shares $1.47 million -19.5%N/A393 $37.50 1/15/202149,200 shares $1.77 million +20.0%N/A0 $35.95 12/31/202075,200 shares $2.70 million +52.9%N/A0 $35.95 12/15/202049,200 shares $1.77 million +20.0%N/A0 $35.95 11/30/202041,000 shares $1.47 million -45.1%N/A136.7 $35.95 10/30/202055,600 shares $1.86 million +3.2%N/A556 $33.40 10/15/202053,900 shares $2.28 million -17.3%N/A179.7 $42.30 9/30/202065,200 shares $2.44 million -39.0%N/A0 $37.40 9/15/2020106,800 shares $3.99 million +23.5%N/A0 $37.40 8/31/202086,500 shares $3.24 million +44.7%N/A865 $37.40 8/14/202059,800 shares $2.13 million +16.8%N/A598 $35.63 7/31/202051,200 shares $1.82 million -2.7%N/A256 $35.63 7/15/202052,600 shares $1.81 million +6.5%N/A0 $34.40 6/30/202049,400 shares $1.89 million -38.6%N/A0 $38.25 6/15/202080,500 shares $3.08 million +8.3%N/A402.5 $38.25 5/29/202074,300 shares $2.93 million +11.1%N/A743 $39.45 5/15/202066,900 shares $1.65 million +6.5%N/A669 $24.60 4/30/202062,800 shares $1.54 million -34.5%N/A0 $24.60 4/15/202095,800 shares $2.36 million +21.1%N/A0 $24.60 3/31/202079,100 shares $1.95 million -23.4%N/A791 $24.60 3/13/2020103,200 shares $2.54 million +19.4%N/A1032 $24.60 2/28/202086,400 shares $2.13 million +10.5%N/A432 $24.60 2/14/202078,200 shares $2.96 million +51.8%N/A782 $37.85 1/31/202051,500 shares $1.86 million +15.0%N/A515 $36.10 1/15/202044,800 shares $1.57 million -7.3%N/A9.1 $34.95 12/31/201948,300 shares $1.74 million +23.5%N/A161 $36.10 ZLDPF Short Interest - Frequently Asked Questions What is Zealand Pharma A/S's current short interest? Short interest is the volume of Zealand Pharma A/S shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 813,400 shares of ZLDPF short. Learn More on Zealand Pharma A/S's current short interest. What is a good short interest ratio for Zealand Pharma A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZLDPF shares currently have a short interest ratio of 136.0. Learn More on Zealand Pharma A/S's short interest ratio. Is Zealand Pharma A/S's short interest increasing or decreasing? Zealand Pharma A/S saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 813,400 shares, an increase of 0.1% from the previous total of 812,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Zealand Pharma A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Zealand Pharma A/S: BeiGene, Ltd. (1.37%), Teva Pharmaceutical Industries Limited (1.98%), Moderna, Inc. (11.90%), Viatris Inc. (1.78%), Genmab A/S (0.32%), Summit Therapeutics Inc. (2.28%), Sarepta Therapeutics, Inc. (6.09%), Dr. Reddy's Laboratories Limited (1.32%), Vaxcyte, Inc. (8.85%), Catalent, Inc. (8.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Zealand Pharma A/S stock? Short selling ZLDPF is an investing strategy that aims to generate trading profit from Zealand Pharma A/S as its price is falling. ZLDPF shares are trading down $1.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Zealand Pharma A/S? A short squeeze for Zealand Pharma A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZLDPF, which in turn drives the price of the stock up even further. How often is Zealand Pharma A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZLDPF, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies BGNE Short Interest TEVA Short Interest MRNA Short Interest VTRS Short Interest GMAB Short Interest SMMT Short Interest SRPT Short Interest RDY Short Interest PCVX Short Interest CTLT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ZLDPF) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
